Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
boston blog main
boston top stories
boulder/denver blog main
boulder/denver top stories
clinical trials
3
×
detroit blog main
detroit top stories
indiana blog main
indiana top stories
life sciences
national
national blog main
national top stories
new york blog main
new york top stories
raleigh-durham blog main
raleigh-durham top stories
3
×
san diego blog main
san diego top stories
san francisco blog main
san francisco top stories
seattle blog main
seattle top stories
texas blog main
texas top stories
wisconsin blog main
wisconsin top stories
alnylam pharmaceuticals
biotech
cancer
fda
spark therapeutics
vertex pharmaceuticals
abeona therapeutics
accent therapeutics
achilles therapeutics
akouos
alder biopharmaceuticals
alexion pharmaceuticals
alopecia areata
What
drug
patients
3
×
bio
fda
market
roundup
advantages
aren’t
bar
brings
cancer
developers
drugs
eisai
expect
flags
gamble
gene
help
higher
imminent
incidence
long
lorcaserin
loss
marketing
medco’s
medicare
medicine
mover
moves
new
news
noteworthy
payers
physicians
plan
post
prices
pricing
Language
unset
Current search:
patients
×
" clinical trials "
×
" raleigh-durham top stories "
×
@xconomy.com
4 years ago
Eisai Pulls Weight Loss Drug From Market After FDA Flags Cancer Risks
@xconomy.com
4 years ago
Bio Roundup: MedCo’s Pricing Plan, Vertex’s Gamble, uBiome Undone
@xconomy.com
5 years ago
Bio Roundup: Medicare Drug Prices, FDA Moves, Gene Therapy News & More